×
About 806 results

ALLMedicine™ Lung Cancer Staging Center

Research & Reviews  377 results

Is Biopsy of Contralateral Hilar N3 Lymph Nodes With Negative PET-CT Scan Findings Nece...
https://doi.org/10.1016/j.chest.2020.10.041
Chest Sainz Zúñiga PV, Martinez-Zayas G et. al.

Jan 4th, 2021 - Systematic endobronchial ultrasound (EBUS)-guided lung cancer staging starts with hilar N3 nodes, proceeding sequentially to mediastinal N3, N2, and N1 nodes, with sampling of all enlarged nodes (size, ≥ 5 mm) by EBUS. However, procedure time is l...

The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resecte...
https://doi.org/10.1016/j.jtcvs.2020.05.097
The Journal of Thoracic and Cardiovascular Surgery; Ma Z, Zhang Y et. al.

Aug 2nd, 2020 - The ninth edition of lung cancer staging system recommends that specific driver mutations should be considered as prognostic factors in survival models. This study comprehensively investigated the prognostic value of Kirsten rat sarcoma viral onco...

Clinical Non-Small Cell Lung Cancer Staging and Tumor Length Measurement Results From U...
https://doi.org/10.1016/j.acra.2020.04.007
Academic Radiology; Wu DY, de Hoyos A et. al.

Jun 21st, 2020 - Examine the accuracy of clinical non-small cell lung cancer staging and tumor length measurements, which are critical to prognosis and treatment planning. Compare clinical and pathological staging and lengths using 10,320 2016 National Cancer Inst...

Prognostic value of epidermal growth factor receptor gene mutation in resected lung ade...
https://doi.org/10.1016/j.jtcvs.2020.05.099
The Journal of Thoracic and Cardiovascular Surgery; Deng C, Zhang Y et. al.

Jun 21st, 2020 - Mutation of the EGFR gene is known as a predictor for the response to EGFR tyrosine kinase inhibitor. Although EGFR mutation status is proposed to be incorporated in the Ninth Edition of the Lung Cancer Staging system, its prognostic value for sur...

What's new in endobronchial ultrasound for mediastinal staging?
https://doi.org/10.1097/MCP.0000000000000686 10.1016/j.jtcvs.2019.10.205
Current Opinion in Pulmonary Medicine; Marcoux M, Ost DE

Jun 3rd, 2020 - The essential role of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in lung cancer diagnosis and staging is now well established. With a growing body of evidence seen over the last decade, the objective of this artic...

see more →

Guidelines  11 results

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer Update
http://ascopubs.org/full/doi/10.1200/JCO.2017.74.6065
Nasser Hanna

Oct 19th, 2017 - Provide evidence-based recommendations updating the 2015 ASCO guideline on systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC).

IASLC Atlas of PD-L1 Testing in Lung Cancer
https://www.iaslc.org/publications/iaslc-atlas-pd-l1-testing-lung-cancer
IASLC

Sep 30th, 2017 - The IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer is a new resource for understanding programmed cell death ligand-1 (PD-L1) immunohistochemistry (IHC) assays.

The IASLC Atlas of EGFR Testing in Lung Cancer
https://www.iaslc.org/publications/iaslc-atlas-egfr-testing-lung-cancer
Myung-Ju Ahn

Sep 30th, 2017 - The IASLC Atlas of EGFR Testing in Lung Cancer provides health care professionals with information on EGFR testing processes and facilitates clinicians’ understanding of how to interpret the results.

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidel...
https://academic.oup.com/annonc/article/28/suppl_4/iv1/3958156
Postmus, P. E.

Jul 12th, 2017 - Lung cancer is the leading cause of cancer mortality worldwide with 1. 8 million newly diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1].

ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiothe...
https://www.thegreenjournal.com/article/S0167-8140(17)30376-6/fulltext
Guckenberger, M.,et al

Jun 30th, 2017 - Stereotactic body radiotherapy (SBRT) has become the standard of care for medically inoperable patients with peripherally located, early stage non-small cell lung cancer (NSCLC), and for those refusing surgical resection. Despite the availability.

see more →

Clinicaltrials.gov  403 results

Is Biopsy of Contralateral Hilar N3 Lymph Nodes With Negative PET-CT Scan Findings Nece...
https://doi.org/10.1016/j.chest.2020.10.041
Chest Sainz Zúñiga PV, Martinez-Zayas G et. al.

Jan 4th, 2021 - Systematic endobronchial ultrasound (EBUS)-guided lung cancer staging starts with hilar N3 nodes, proceeding sequentially to mediastinal N3, N2, and N1 nodes, with sampling of all enlarged nodes (size, ≥ 5 mm) by EBUS. However, procedure time is l...

The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resecte...
https://doi.org/10.1016/j.jtcvs.2020.05.097
The Journal of Thoracic and Cardiovascular Surgery; Ma Z, Zhang Y et. al.

Aug 2nd, 2020 - The ninth edition of lung cancer staging system recommends that specific driver mutations should be considered as prognostic factors in survival models. This study comprehensively investigated the prognostic value of Kirsten rat sarcoma viral onco...

Clinical Non-Small Cell Lung Cancer Staging and Tumor Length Measurement Results From U...
https://doi.org/10.1016/j.acra.2020.04.007
Academic Radiology; Wu DY, de Hoyos A et. al.

Jun 21st, 2020 - Examine the accuracy of clinical non-small cell lung cancer staging and tumor length measurements, which are critical to prognosis and treatment planning. Compare clinical and pathological staging and lengths using 10,320 2016 National Cancer Inst...

Prognostic value of epidermal growth factor receptor gene mutation in resected lung ade...
https://doi.org/10.1016/j.jtcvs.2020.05.099
The Journal of Thoracic and Cardiovascular Surgery; Deng C, Zhang Y et. al.

Jun 21st, 2020 - Mutation of the EGFR gene is known as a predictor for the response to EGFR tyrosine kinase inhibitor. Although EGFR mutation status is proposed to be incorporated in the Ninth Edition of the Lung Cancer Staging system, its prognostic value for sur...

What's new in endobronchial ultrasound for mediastinal staging?
https://doi.org/10.1097/MCP.0000000000000686 10.1016/j.jtcvs.2019.10.205
Current Opinion in Pulmonary Medicine; Marcoux M, Ost DE

Jun 3rd, 2020 - The essential role of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in lung cancer diagnosis and staging is now well established. With a growing body of evidence seen over the last decade, the objective of this artic...

see more →

News  15 results

Networks: NSCLC staging, MAPAH, cough in teen athletes
https://www.mdedge.com/chestphysician/article/138082/society-news/networks-nsclc-staging-mapah-cough-teen-athletes

May 12th, 2017 - Interventional Chest/Diagnostic Procedures Update: 8th ed IASLC lung cancer staging guidelines The new 8th edition guidelines on the staging of non-small cell lung cancer sponsored by the International Association for the Study of Lung Cancer (IAS.

IASLC lung cancer staging project proposes changes for new TNM classification
https://www.mdedge.com/chestphysician/article/109725/surgical-oncology/iaslc-lung-cancer-staging-project-proposes-changes
Mark S. Lesney, MDedge News

Jun 18th, 2016 - The International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee has developed proposals for revision of the T, N, and M categories of the 8th edition of the TNM Classification for lung cancer due to be p.

FDG-PET/CT leads pack for small-cell lung cancer staging
https://www.mdedge.com/hematology-oncology/article/108847/lung-cancer/fdg-pet/ct-leads-pack-small-cell-lung-cancer-staging
Heidi Splete

May 13th, 2016 - For pretreatment staging of small-cell lung cancer (SCLC) the use of positron-emission tomography combined with CT was more sensitive compared with several other tests, according to a new report on a review of studies. Overall, positron emission t.

Clinical advances drive lung cancer staging, classification changes
https://www.mdedge.com/familymedicine/article/102701/lung-cancer/clinical-advances-drive-lung-cancer-staging-classification/page/0/1
ACS Surgery News;

Sep 17th, 2015 - The proposed revision would continue to group in the M1a category cases with pleural/pericardial effusions, contralateral/bilateral lung nodules, contralateral/bilateral pleural nodules, or a combination of multiple parameters. However, single met.

Refining Lung Cancer Staging in the Molecular Oncology Era
https://www.medscape.com/viewarticle/844841

May 18th, 2015 - Identification of Independent Primary Tumors and Intrapulmonary Metastases Using DNA Rearrangements in Non-Small-Cell Lung Cancer Murphy SJ, Aubry MC, Harris FR, et al J Clin Oncol. 2014;32:4050-4058 Ambiguity in staging of lung nodules is a commo...

see more →